XML 46 R30.htm IDEA: XBRL DOCUMENT
v3.21.2

Equity Plans and Stock-Based Compensation (Tables) | 6 Months Ended
--- | ---
Jun. 30, 2021
Share Based Compensation [Abstract] |
Option Activity under Stock-Based Compensation Plans | In January 2021, we adopted the Dynavax Technologies Corporation 2021 Inducement Award Plan (“2021 Inducement Plan”), pursuant to which we reserved 1,500,000 shares of common stock for issuance under the plan to be used exclusively for grants of awards to individuals who were not previously employees or directors of the Company. In June 2021, we amended the 2021 Inducement Plan (“Amended 2021 Inducement Plan”) to increase the number of shares of common stock reserved under the 2021 Inducement Plan to 3,250,000. In May 2021, the stockholders approved the amendment and restatement of our 2014 Employee Stock Purchase Plan (the “Amended and Restated 2014 Employee Stock Purchase Plan”). The maximum number of shares of common stock that may be issued under the Amended and Restated 2014 Employee Stock Purchase Plan is 1,850,000. As of June 30, 2021, the 2018 Equity Incentive Plan, as amended, (“Amended 2018 EIP”), the Amended 2021 Inducement Plan and the Amended and Restated 2014 Employee Stock Purchase Plan are our active plans. Under the Amended 2018 EIP, the aggregate number of shares of our common stock that may be issued to employees and directors (subject to adjustment for certain changes in capitalization) is 22,517,869. Under our stock-based compensation plans, option awards generally vest over a three or four-year period contingent upon continuous service, and expire seven to ten years from the date of grant (or earlier upon termination of continuous service). Option activity under our stock-based compensation plans during the six months ended June 30, 2021 was as follows (in thousands except per share amounts):
|  | Shares Underlying Outstanding Options |  |  | Weighted- Average Exercise Price Per Share |  |  | Weighted- Average Remaining Contractual Term (years) |  |  | Aggregate Intrinsic Value |
Balance at December 31, 2020 |  |  | 8,505 |  |  | $ | 11.57 |  |  |  |  |  |  |  |  |
Options granted |  |  | 2,817 |  |  |  | 9.31 |  |  |  |  |  |  |  |  |
Options exercised |  |  | (308 | ) |  |  | 4.69 |  |  |  |  |  |  |  |  |
Options cancelled: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Options forfeited (unvested) |  |  | (376 | ) |  |  | 7.74 |  |  |  |  |  |  |  |  |
Options expired (vested) |  |  | (391 | ) |  |  | 18.63 |  |  |  |  |  |  |  |  |
Balance at June 30, 2021 |  |  | 10,247 |  |  | $ | 11.03 |  |  |  | 4.36 |  |  | $ | 17,136 |
Vested and expected to vest at June 30, 2021 |  |  | 9,876 |  |  | $ | 11.12 |  |  |  | 4.29 |  |  | $ | 16,644 |
Exercisable at June 30, 2021 |  |  | 5,966 |  |  | $ | 13.04 |  |  |  | 3.03 |  |  | $ | 9,627 |
Summary of Restricted Stock Units Activity | Restricted stock unit activity under our stock-based compensation plans during the six months ended June 30, 2021 was as follows (in thousands except per share amounts):
|  | Number of Shares (in thousands) |  |  | Weighted-Average Grant-Date Fair Value Per Share |
Non-vested as of December 31, 2020 |  |  | 1,794 |  |  | $ | 7.23 |
Granted |  |  | 1,797 |  |  |  | 9.43 |
Vested |  |  | (537 | ) |  |  | 8.85 |
Forfeited |  |  | (276 | ) |  |  | 8.24 |
Non-vested as of June 30, 2021 |  |  | 2,778 |  |  | $ | 8.24 |
Summary Of Performance Based Restricted Stock Unit | We granted performance-based restricted stock unit (“PSU”) to certain executives in February 2021. These PSUs vest upon a specified market condition. The summary of PSU activities for the six months ended June 30, 2021 is as follows:
|  | Number of Shares (in thousands) |  |  | Weighted-Average Grant-Date Fair Value Per Share |
Non-vested as of December 31, 2020 |  |  | - |  |  | $ | - |
Granted |  |  | 297 |  |  |  | 8.40 |
Forfeited |  |  | (60 | ) |  |  | 8.40 |
Non-vested as of June 30, 2021 |  |  | 237 |  |  | $ | 8.40 |
Fair Value-Based Measurements and Weighted-Average Assumptions | The fair value-based measurement of each option is estimated on the date of grant using the Black-Scholes option valuation model. The fair value of each RSU is determined at the date of grant using our closing stock price. The fair value of each PSU is estimated using the Monte Carlo simulation method on the date of grant. The weighted-average assumptions used in the calculations of these fair value measurements are as follows:
|  | Stock Options |  |  | Stock Options |  |  | Market-Based Performance Stock Unit (“PSUs”) |
|  | Three Months Ended |  |  | Six Months Ended |  |  | Six Months Ended |
|  | June 30, |  |  | June 30, |  |  | June 30, 2021 |
|  | 2021 |  |  | 2020 |  |  | 2021 |  |  | 2020 |  |  |  |  |
Weighted-average fair value per share |  | $ | 6.20 |  |  | $ | 3.77 |  |  | $ | 6.57 |  |  | $ | 3.61 |  |  | $ | 8.40 |
Risk-free interest rate |  |  | 0.9 | % |  |  | 0.3 | % |  |  | 0.6 | % |  |  | 1.2 | % |  | From 0.03% to 1.92% |
Expected life (in years) |  |  | 4.5 |  |  |  | 4.5 |  |  |  | 4.5 |  |  |  | 4.5 |  |  |  | 2.9 |
Volatility |  |  | 0.9 |  |  |  | 0.9 |  |  |  | 1.0 |  |  |  | 0.9 |  |  |  | 0.9 |
Stock-Based Compensation Expense | The components of stock-based compensation expense were as follows (in thousands):
|  | Three Months Ended |  |  | Six Months Ended |
|  | June 30, |  |  | June 30, |
|  | 2021 |  |  | 2020 |  |  | 2021 |  |  | 2020 |
Research and development |  | $ | 937 |  |  | $ | 774 |  |  | $ | 1,809 |  |  | $ | (799 | )
Selling, general and administrative |  |  | 3,445 |  |  |  | 2,491 |  |  |  | 6,589 |  |  |  | 4,933 |
Cost of sales - product |  |  | 155 |  |  |  | 179 |  |  |  | 324 |  |  |  | 315 |
Inventory |  |  | 487 |  |  |  | 644 |  |  |  | 1,025 |  |  |  | 1,417 |
Total |  | $ | 5,024 |  |  | $ | 4,088 |  |  | $ | 9,747 |  |  | $ | 5,866 |

X
- Definition Summary of performance based restricted stock unit. + References No definition available. + Details
Name: | dvax_ScheduleOfPerformanceBasedRestrictedStockUnitTableTextBlock
Namespace Prefix: | dvax_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of cost recognized for award under share-based payment arrangement by plan. Includes, but is not limited to, related tax benefit. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (h)(1) -URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901 + Details
Name: | us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of number, weighted-average exercise price or conversion ratio, aggregate intrinsic value, and weighted-average remaining contractual term for outstanding options that are fully vested and expected to vest. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (e)(1) -URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(1) -URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (f)(2) -URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901 + Details
Name: | us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_ShareBasedCompensationAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration